Index S&P 500
P/E 20.37
EPS (ttm) 5.25
Insider Own 0.14%
Shs Outstand 199.60M
Perf Week -3.35%
Market Cap 21.28B
Forward P/E 12.46
EPS next Y 8.58
Insider Trans 0.00%
Shs Float 198.80M
Perf Month -2.33%
Income 1.08B
PEG 3.02
EPS next Q 2.30
Inst Own 92.83%
Short Float 3.34%
Perf Quarter 1.68%
Sales 7.60B
P/S 2.80
EPS this Y 5.81%
Inst Trans -2.40%
Short Ratio 4.49
Perf Half Y -0.50%
Book/sh 62.00
P/B 1.72
EPS next Y 7.41%
ROA 5.05%
Short Interest 6.64M
Perf Year -9.38%
Cash/sh 2.86
P/C 37.40
EPS next 5Y 6.74%
ROE 8.71%
52W Range 101.47 - 133.90
Perf YTD -12.15%
Dividend Est. 0.87 (0.82%)
P/FCF 19.36
EPS past 5Y -
ROI 6.33%
52W High -20.16%
Beta 1.02
Dividend TTM 0.96 (0.90%)
Quick Ratio 0.70
Sales past 5Y -1.20%
Gross Margin 62.71%
52W Low 5.36%
ATR (14) 2.22
Dividend Ex-Date Sep 30, 2024
Current Ratio 1.36
EPS Y/Y TTM 131.89%
Oper. Margin 18.93%
RSI (14) 42.25
Volatility 2.47% 1.93%
Employees 18000
Debt/Eq 0.52
Sales Y/Y TTM 4.34%
Profit Margin 14.27%
Recom 2.55
Target Price 123.76
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q 58.38%
Payout 19.66%
Rel Volume 1.06
Prev Close 108.40
Sales Surprise 1.44%
EPS Surprise -0.22%
Sales Q/Q 4.03%
Earnings Oct 30 BMO
Avg Volume 1.48M
Price 106.91
SMA20 -2.93%
SMA50 -0.51%
SMA200 -5.73%
Trades
Volume 1,572,894
Change -1.37%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-10-24 Initiated
Wolfe Research
Peer Perform
Jul-01-24 Downgrade
Piper Sandler
Overweight → Neutral
$140 → $115
May-30-24 Initiated
Goldman
Neutral
$129
May-21-24 Upgrade
Argus
Hold → Buy
$150
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$135 → $125
Oct-20-23 Initiated
ROTH MKM
Neutral
$120
Aug-28-23 Upgrade
BTIG Research
Neutral → Buy
$139
May-03-23 Upgrade
BofA Securities
Underperform → Neutral
Apr-11-23 Upgrade
Evercore ISI
In-line → Outperform
$135 → $148
Mar-31-23 Upgrade
Jefferies
Underperform → Hold
$115 → $130
Mar-29-23 Initiated
UBS
Sell
$112
Mar-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$135 → $145
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$125 → $141
Jan-05-23 Upgrade
Raymond James
Mkt Perform → Outperform
$144
Jan-03-23 Downgrade
Evercore ISI
Outperform → In-line
$130
Nov-23-22 Upgrade
Wells Fargo
Underweight → Equal Weight
Oct-18-22 Initiated
Barclays
Underweight
$104
Oct-12-22 Initiated
Jefferies
Underperform
$95
May-27-22 Downgrade
Needham
Buy → Hold
Apr-13-22 Downgrade
Truist
Buy → Hold
$128 → $142
Show Previous Ratings
Dec-10-24 11:14PM
Dec-05-24 08:52AM
07:36AM
Dec-04-24 07:30AM
Nov-29-24 11:32AM
01:54AM
Loading…
Nov-26-24 01:54AM
Nov-25-24 04:05PM
Nov-21-24 07:30AM
Nov-18-24 07:30AM
Nov-16-24 10:11AM
Nov-13-24 07:30AM
Nov-07-24 07:30AM
Nov-04-24 08:19AM
06:14AM
Oct-31-24 07:19PM
03:10AM
Loading…
03:10AM
(Thomson Reuters StreetEvents)
03:06AM
Oct-30-24 09:30AM
07:53AM
07:40AM
06:36AM
(Associated Press Finance)
06:30AM
Oct-29-24 09:15AM
Oct-28-24 04:34PM
07:30AM
Oct-25-24 03:05AM
Oct-23-24 10:01AM
Oct-16-24 07:35AM
Oct-09-24 07:30AM
Sep-18-24 07:06AM
11:31AM
Loading…
Sep-06-24 11:31AM
Sep-05-24 05:16PM
04:04PM
(Investor's Business Daily)
03:59PM
03:29PM
11:37AM
07:30AM
Aug-29-24 04:43PM
Aug-21-24 07:30AM
Aug-15-24 09:02AM
Aug-12-24 08:53AM
Aug-09-24 06:54AM
01:12AM
Aug-08-24 09:40AM
06:32AM
Aug-07-24 05:01PM
12:13PM
09:30AM
07:44AM
07:40AM
06:39AM
(Associated Press Finance)
06:30AM
06:30AM
Aug-06-24 04:09PM
Aug-02-24 09:15AM
Jul-29-24 07:00AM
Jul-25-24 10:48AM
Jul-24-24 06:12AM
Jul-19-24 09:40AM
Jul-17-24 09:50AM
Jul-08-24 07:30AM
Jun-20-24 07:30AM
Jun-14-24 09:16AM
07:29AM
Jun-13-24 11:22AM
06:53AM
Jun-12-24 08:38AM
06:00AM
Jun-11-24 07:30AM
Jun-04-24 12:14PM
07:30AM
01:38AM
May-30-24 12:21PM
May-29-24 05:02PM
09:40AM
May-23-24 07:10PM
May-21-24 07:55AM
May-20-24 08:30AM
06:00AM
May-15-24 08:59AM
03:11AM
May-13-24 09:40AM
07:00AM
May-09-24 07:58AM
May-06-24 07:30AM
May-03-24 12:57PM
11:17AM
11:07AM
09:53AM
09:41AM
08:31AM
08:23AM
08:18AM
07:37AM
07:19AM
07:08AM
07:04AM
03:10AM
May-02-24 01:52PM
11:56AM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Upadhyay Suketu Exec. VP, CFO Nov 10 '24 Option Exercise 0.00 15,948 0 36,842 Nov 12 04:32 PM VAN ZUILEN WILFRED Group Pres, EMEA Jul 01 '24 Option Exercise 0.00 2,633 0 9,800 Jul 03 04:23 PM Yi Sang Group President, Asia Pacific May 31 '24 Sale 114.69 12,857 1,474,582 5,322 Jun 04 04:21 PM Stellato Paul A VP, Controller & CAO Jun 01 '24 Option Exercise 0.00 627 0 1,579 Jun 04 04:20 PM Winkler Lori SVP and CHRO Apr 01 '24 Option Exercise 0.00 772 0 3,551 Apr 03 04:35 PM Winkler Lori SVP and CHRO Mar 06 '24 Option Exercise 0.00 1,757 0 3,207 Mar 08 05:05 PM VAN ZUILEN WILFRED Group Pres, EMEA Mar 06 '24 Option Exercise 0.00 2,163 0 7,427 Mar 08 05:05 PM Upadhyay Suketu Exec. VP, CFO Mar 06 '24 Option Exercise 0.00 4,561 0 22,683 Mar 08 05:05 PM Tornos Ivan President & CEO Mar 06 '24 Option Exercise 0.00 10,270 0 32,395 Mar 08 05:04 PM Stellato Paul A VP, Controller & CAO Mar 06 '24 Option Exercise 0.00 609 0 1,176 Mar 08 05:04 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 06 '24 Option Exercise 0.00 2,095 0 50,046 Mar 08 05:03 PM Ellingson Rachel SVP & Chief Strategy Officer Mar 06 '24 Option Exercise 0.00 1,419 0 7,291 Mar 08 05:03 PM Bezjak Mark President, Americas Mar 06 '24 Option Exercise 0.00 1,622 0 4,753 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Option Exercise 91.53 1,705 156,059 19,884 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 06 '24 Option Exercise 0.00 2,365 0 18,179 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Sale 126.86 1,705 216,296 18,179 Mar 08 05:03 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 01 '24 Option Exercise 0.00 1,641 0 48,597 Mar 05 05:02 PM Yi Sang Group President, Asia Pacific Mar 01 '24 Option Exercise 0.00 2,052 0 15,814 Mar 05 04:59 PM Winkler Lori SVP and CHRO Mar 02 '24 Option Exercise 0.00 186 0 1,496 Mar 05 04:58 PM Upadhyay Suketu Exec. VP, CFO Feb 25 '24 Option Exercise 0.00 7,043 0 20,213 Feb 27 08:58 PM Tornos Ivan President & CEO Feb 25 '24 Option Exercise 0.00 7,513 0 25,153 Feb 27 08:58 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 25 '24 Option Exercise 0.00 4,580 0 48,725 Feb 27 08:57 PM Ellingson Rachel SVP & Chief Strategy Officer Feb 25 '24 Option Exercise 0.00 1,762 0 6,460 Feb 27 08:57 PM Winkler Lori SVP and CHRO Feb 25 '24 Option Exercise 0.00 1,294 0 1,661 Feb 27 08:56 PM Bezjak Mark President, Americas Feb 25 '24 Option Exercise 0.00 1,528 0 3,535 Feb 27 08:56 PM Yi Sang Group President, Asia Pacific Feb 25 '24 Option Exercise 0.00 5,047 0 13,762 Feb 27 08:55 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Option Exercise 91.53 26,156 2,394,059 70,301 Feb 26 06:02 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Sale 128.62 26,156 3,364,126 44,145 Feb 26 06:02 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite